Resveratrol triggers protective autophagy through the ceramide/Akt/mTOR pathway in melanoma B16 cells.
Nutr Cancer
; 66(3): 435-40, 2014.
Article
em En
| MEDLINE
| ID: mdl-24579778
Resveratrol (3,5,4'-trihydroxy-trans-stilbene, RSV), a natural polyphenolic compound, is known as a promising anti-cancer agent. In this study, we showed that RSV could inhibit the growth of B16 cells via induction of apoptosis. Moreover, our results showed for the first time that RSV induced autophagy in B16 cells, which might occur through ceramide accumulation and Akt/mTOR pathway inhibition. Inhibition of autophagy by an autophagic inhibitor 3-methyladenine (3-MA) or si-Beclin 1 enhanced RSV-induced cytotoxicity and apoptosis. Thus, autophagy inhibition represents a promising approach to improve the efficacy of RSV in the treatment of patients with melanoma.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Estilbenos
/
Melanoma Experimental
/
Ceramidas
/
Proteínas Proto-Oncogênicas c-akt
/
Serina-Treonina Quinases TOR
Limite:
Animals
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article